Christopher Gibson

Director, Recursion Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.2M

Companies

Latest trade

Jun 5, 2026

Companies

Recursion Pharmaceuticals, Inc.Director −$3.4M

Trades

RXRX Sold 40,000 shares at $3.62 · planned $0.1M Jun 5

RXRX Sold 40,000 shares at $3.08 · planned $0.1M May 22

RXRX Sold 40,000 shares at $3.37 · planned $0.1M May 7

RXRX Sold 40,000 shares at $3.61 · planned $0.1M Apr 22

RXRX Sold 40,000 shares at $3.10 · planned $0.1M Apr 7

RXRX Sold 40,000 shares at $3.25 · planned $0.1M Mar 23

RXRX Sold 40,000 shares at $3.46 · planned $0.1M Feb 19

RXRX Sold 40,000 shares at $4.12 · planned $0.2M Feb 4

RXRX Sold 40,000 shares at $4.47 · planned $0.2M Jan 20

RXRX Sold 40,000 shares at $4.25 · planned $0.2M Jan 5

RXRX Sold 40,000 shares at $4.50 · planned $0.2M Dec 19

RXRX Sold 40,000 shares at $4.63 · planned $0.2M Dec 4

RXRX Sold 40,000 shares at $4.16 · planned $0.2M Nov 19

RXRX Sold 40,000 shares at $5.21 · planned $0.2M Nov 4

RXRX Sold 100,000 shares at $5.70 · planned $0.6M Oct 23

RXRX Sold 100,000 shares at $6.04 · planned $0.6M Oct 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.